NeurologyLive® Friday 5 — March 15, 2024

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: FDA Action Update, February 2024: Clearance, Priority Review, and Designation

The FDA was busy in February 2024, making a number of decisions on potential new therapeutic agents including a clearance for a clinical trial, granting a priority review for efficacy supplement, and granting a fast track designation.

2: Raising Awareness for the Lasting Effects of Traumatic Brain Injury: Shae Datta, MD

The neurologist and migraine expert at NYU Langone Health provided perspective on TBI Awareness Month and the importance of accurate detection and swift care for trauamatic brain injury. [WATCH TIME: 4 minutes]

3: Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPC

The director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]

4: NeuroVoices: Michael S. Okun, MD, on the Potential Benefit of Continuous Physical Therapy in Parkinson Disease

In this week's NeuroVoices Q&A, the national medical advisor for the Parkinson's Foundation discussed the importance of continuous and ‘spaced’ physical therapy for Parkinson disease, highlighting the underutilization of this approach.

5: Wearable Devices in Parkinson’s Disease (PD)

In episode 1 of the "Device-Aided Management of Parkinson's Disease" video series, Zoltan Mari, MD, leads a discussion on the benefits of wearable devices in Parkinson Disease, and emphasizes the major public health impact of the disease.